Altogether, these observations demonstrate that specific glycan patterns on tumor cells correlate with clinical outcome of melanoma patients, especially GlcNAc, NeuAc, TF-antigen and Fuc motifs being associated with poor outcome, whereas Man and Glc residues elicit better survival. The gene discussed is TF; the disease is melanoma.